<DOC>
	<DOCNO>NCT01167023</DOCNO>
	<brief_summary>The purpose trial ass safety Prasugrel adult patient sickle cell disease ( SCD ) monitoring rate severity hemorrhagic event require medical intervention compare placebo 30 day .</brief_summary>
	<brief_title>Prasugrel Versus Placebo Adult Sickle Cell Disease</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>Adults Sickle Cell Disease ( SCD ) . Are great equal 50 kilogram ( kg ) time screen . Are currently treat investigational drug ( use hydroxyurea , investigational drug , permit protocol patient stable dose least 30 day prior randomization sign hematological toxicity screening . Agree use reliable method birth control study woman childbearing potential due surgical sterilization ( hysterectomy bilateral oophorectomy tubal ligation ) menopause . Acute painful crisis ( require medical attention ) within 30 day prior screen . Have concomitant medical illness ( example , terminal malignancy ) , opinion investigator , associate reduce survival expected treatment period ( approximately 30 day ) . Severe hepatic dysfunction ( cirrhosis , portal hypertension , aspartate aminotransferase ( AST ) great equal 3x upper limit normal [ ULN ] ) . Renal dysfunction require chronic dialysis . Contraindication antiplatelet therapy . History intolerance allergy approve thienopyridines . Have sign symptom infection . Hypertension ( systolic blood pressure &gt; 180 millimeter mercury ( mm Hg ) diastolic blood pressure &gt; 110 mm Hg ) time screen randomization . Hematocrit &lt; 18 % . Any history bleeding diathesis , bleed require inhospital treatment , papillary necrosis . Active internal bleeding . History spontaneous gastrointestinal ( GI ) bleed require inhospital treatment . Gross hematuria . Microhematuria , common SCD patient , contraindication . Platelet count &lt; 100,000 per cubic millimeter . Any history intraocular hemorrhage . Prior history transient ischemic attack ( TIA ) , ischemic stroke , hemorrhagic stroke , intracranial hemorrhage . Known history intracranial neoplasm , arteriovenous malformation , aneurysm . Have clinical finding , judgment investigator , associate increase risk bleeding . Have international normalize ratio ( INR ) great 1.5 screening . Have recent surgery ( within 30 day prior screen ) schedule undergo surgery within next 60 day . History menorrhagia require medical intervention .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Sickle Cell Disease</keyword>
	<keyword>Sickle Cell Anemia</keyword>
	<keyword>Adult</keyword>
</DOC>